Evidence Hub

The small molecule CLP257 does not modify activity of the K+–Cl− co-transporter KCC2 but does potentiate GABAA receptor activity

Ross A. Cardarelli, Karen Jones, L. Pisella, Heike J Wobst, Lisa McWilliams, P. T. Sharpe, M. P. Burnham, D. J. Baker et al.

Nature Medicine, 2017

18 citations

Abstract

To the Editor: The neuronal K+–Cl– co-transporter KCC2 (also known as solute carrier family 12 member 5, or SLC12A5) critically maintains the neuronal Cl– gradient to establish hyperpolarizing signaling by GABAA receptors, the primary mediators of fast synaptic inhibition in the brain. These receptors are also the principal targets of benzodiazepines, neurosteroids, and intravenous general anesthetics1. The downregulation of KCC2 in neuropathic pain models and seizurerelated disorders indentifies it as a putative therapeutic target. Through a small-molecule screen in neuroblastoma/glioma-derivative NG108-15 cells, Gagnon et al.2 identified CLP257 as a ‘KCC2 activator’. We therefore sought to confirm and further determine its mechanism of action. We began our investigation by using gramicidin perforated-patch recordings to measure the levels of intracellular Cl– ([Cl]i) in NG108-15 cells that were cultured as detailed in the original report. We observed no change in intracellular Cl– values after a 5-h exposure to CLP257, which according to the original paper would produce an easily detectable ~23 mM reduction in Cl– (Fig. 1a). Furthermore, acute administration of the selective KCC2 inhibitor VU0463271 did not affect Cl– levels in either vehicleor CLP257-treated cells (Supplementary Fig. 1)3. In parallel experiments, we analyzed the actions of CLP257 on KCC2 function using fluorescence resonance energy transfer (FRET)-based Cl– imaging that reproduced the conditions of the…

How strong is the evidence?

Evidence Hub reads this as a editorial / letter, done in animal, not in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free